Form 4: ReposiTrak CEO Sells Shares Under Pre-Arranged Charitable Plan

ReposiTrak, Inc.'s Chief Executive Officer and 10% owner, Randall K. Fields, sold 7,500 shares of common stock in early July 2025 through a Rule 10b5-1 trading plan to fulfill charitable commitments.

Summary

• Randall K. Fields, the Chief Executive Officer, Director, and 10% Owner of ReposiTrak, Inc. (TRAK), reported sales of common stock.
• On July 7, 2025, 2,000 shares of common stock were sold at a weighted average price of $19.8488 per share, with prices ranging from $19.54 to $20.05.
• On July 8, 2025, an additional 5,500 shares of common stock were sold at a weighted average price of $19.5748 per share, with prices ranging from $19.445 to $19.80.
• The total number of shares sold across both transactions was 7,500.
• These sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
• The trading plan was established to enable Mr. Fields to meet some of his charitable commitments.
• Following these transactions, Mr. Fields directly beneficially owns 3,683,955 shares of Common Stock.
• Indirect beneficial ownership includes 147,000 shares of Common Stock by RK Fields Charitable 2022, LLC, 615,260 shares of Common Stock and 531,432 shares of Series B Preferred Stock by Riverview Financial Corp., 30,667 shares of Common Stock and 12,322 shares of Series B Preferred Stock by Spouse, and 333,643 shares of Common Stock by Fields Management, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the sales were pre-arranged under a 10b5-1 plan for charitable purposes, which mitigates concerns about management's view of the company's future prospects.

Positives

• The stock sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating the transactions were scheduled in advance and not a reaction to recent negative company developments.
• The stated purpose of the sales is to meet charitable commitments, which is a common and generally well-understood reason for insider dispositions.

Negatives

• Insider selling, even if pre-arranged, can sometimes be perceived negatively by the market, potentially leading to short-term downward pressure on the stock price.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it primarily reports insider transactions.

Management Comments

• The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
• The Trading Plan was established to enable the Reporting Person to meet some of his charitable commitments.

Industry Context

This Form 4 filing details specific insider trading activity for ReposiTrak, Inc. and does not provide broader industry trends or competitive analysis.

Related Party Transactions

• Sales of common stock by Randall K. Fields, the Chief Executive Officer, Director, and 10% Owner.
• Indirect beneficial ownership of common stock and Series B Preferred Stock through RK Fields Charitable 2022, LLC, Riverview Financial Corp., Spouse, and Fields Management, Inc.

Stakeholder Impact

• Shareholders may observe the insider selling, but the pre-arranged nature and charitable purpose of the sales could alleviate concerns about the company's outlook.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Next Steps

• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported ranges.

Key Dates

Recommendation

Keywords

ReposiTrak, TRAK, Randall K. Fields, insider trading, Form 4, stock sale, 10b5-1 plan, CEO, director, 10% owner, common stock, charitable commitments